About us Contacts Drug interactions: 390 212
Drug search by name

Divalproex and Phenobarbital Elixir

Determining the interaction of Divalproex and Phenobarbital Elixir and the possibility of their joint administration.

Check result:
Divalproex <> Phenobarbital Elixir
Relevance: 25.04.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Before taking divalproex sodium, tell your doctor if you also use PHENobarbital. You may need dose adjustments or special tests in order to safely take both medications together. This combination may increase the levels of PHENobarbital in your body. You should notify your doctor if you have symptoms of excessive sedation or lethargy. You should avoid driving until you know how these medications will affect you. It is important that you tell your healthcare provider about all other medications that you are using including vitamins and herbs. Do not stop using your medications without first talking to your doctor first.

Professional:

MONITOR: Valproate may increase the plasma levels of phenobarbital. The proposed mechanism may involve valproate inhibition of CYP450-mediated metabolism of the barbiturate. In healthy subjects, coadministration of valproate (250 mg twice daily for 14 days) with phenobarbital (60 mg once) resulted in a 50% increase in half-life and a 30% reduction in the plasma clearance of phenobarbital. In addition, the fraction of phenobarbital dose excreted unchanged increased by 50% when administered with valproate. In contrast, phenobarbital may cause a decrease in valproate plasma concentrations by inducing the enzymatic metabolism of valproate. Central nervous system- and/or respiratory-depressant effects may also be additively or synergistically increased in patients taking valproate and phenobarbital concomitantly, especially in elderly or debilitated patients.

MANAGEMENT: Patients started on combination therapy should be closely monitored for clinical and laboratory evidence of phenobarbital toxicity. They should be advised to notify their doctor if they experience excessive sedation or lethargy. Reductions in the phenobarbital dosage may be required; some authorities recommend reducing the phenobarbital dose by one-third to one-half when administered with valproate. Monitoring of the plasma concentrations of both drugs when starting, stopping, or changing the dose of either drug is recommended. During concomitant use of these drugs, patients should be monitored for potentially excessive or prolonged CNS and respiratory depression.

References
  • Bourgeois BF "Pharmacologic interactions between valproate and other drugs." Am J Med 84 (1988): 29-33
  • Henriksen O, Johannessen SI "Clinical and pharmacokinetic observations on sodium valproate: a 5-year follow-up study in 100 children with epilepsy." Acta Neurol Scand 65 (1982): 504-23
  • Cerner Multum, Inc. "Australian Product Information." O 0
  • Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  • Gram L, Wulff K, Rasmussen KE, et al "Valproate sodium: a controlled clinical trial including monitoring of drug levels." Epilepsia 18 (1977): 141-8
  • Riva R, Albani F, Contin M, Baruzzi A "Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations." Clin Pharmacokinet 31 (1996): 470-93
  • Sackellares JC, Sato S, Dreifuss FE, Penry JK "Reduction of steady-state valproate levels by other antiepileptic drugs." Epilepsia 22 (1981): 437-41
  • Patel IH, Levy RH, Cutler RE "Phenobarbital-valproic acid interaction." Clin Pharmacol Ther 27 (1980): 515-21
  • Windorfer A, Sauer W, Gadeke R "Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug." Acta Paediatr Scand 64 (1975): 771-2
  • Bruni J, Wilder BJ, Perchalski RJ, Hammond EJ, Villarreal HJ "Valproic acid and plasma levels of phenobarbital." Neurology 30 (1980): 94-7
  • Wilder BJ, Willmore LJ, Bruni J, Villarreal HJ "Valproic acid: interaction with other anticonvulsant drugs." Neurology 28 (1978): 892-6
Divalproex

Generic Name: divalproex sodium

Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon

Synonyms: Divalproex sodium

Phenobarbital Elixir

Generic Name: phenobarbital

Brand name: Solfoton, Luminal

Synonyms: Phenobarbital, PHENobarbital

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle
Disease interaction